Dark

KALV
KalVista Pharmaceuticals, Inc. Common Stock
stock NASDAQ

At Close

Dec 26, 2025 3:59:51 PM EST

15.18USD-3.895%(-0.61)732,041

0.00Bid 0.00Ask 0.00Spread

Pre-market

Dec 24, 2025 8:48:30 AM EST

15.55USD-1.520%(-0.24)0

After-hours

Dec 26, 2025 4:04:30 PM EST

15.17USD-0.033%(-0.01)48,545

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

766.28M

CEO

Thomas Crockett

Headquarters

Cambridge, Massachusetts, USA

Industry

Biotechnology

Last Split

Nov 22, 20161for14reverse

XENT EYEG KOOL SNOA XLV

KALV Stats

Avg. Vol. 10 Day

920,065

Avg. Vol. 30 Day

1,396,705

Employees

Market Cap

766,281,802

Shares Out.

50,546,293

On/Off Exchange

54%/46%

6 Month Beta

0.91

1 Year Beta

0.74

2 Year Beta

0.85

3 Year Beta

0.95

52 Week Low

7.30

52 Week High

17.30

SMA50

13.47

SMA200

13.01

1 Week

-0.46%

1 Month

+4.77%

3 Month

+22.26%

6 Month

+32.87%

1 Year

+77.73%

2 Year

+25.91%

5 Year

-9.65%

Profile

kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.

KALV Stock Summary

KalVista Pharmaceuticals, Inc. Common Stock (NASDAQ:KALV) stock price today is $15.18, and today's volume is 732,041. KALV is down -3.895% today. The 30 day average volume is 1,396,705. KALV market cap is 766.28M with 50,546,293 shares outstanding.